ArticleBMC infectious diseases2010
Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness.
Article in BMC infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 5 syntheses or guidelines pooled it, 129 citations in OpenAlex.
- Burden of Chikungunya Fever and Its Economic and Social Impacts Worldwide: A Systematic Review.Tropical medicine & international health : TM & IH · 2025Pooled it
- Assessing chikungunya's economic burden and impact on health-related quality of life: Two systematic literature reviews.PLoS neglected tropical diseases · 2025Pooled it
- A systematic review and meta-analysis of neuropathic pain associated with coronavirus disease 2019.European journal of pain (London, England) · 2023Pooled it
- Update on the treatment of musculoskeletal manifestations in chikungunya fever: a guideline.Revista da Sociedade Brasileira de Medicina Tropical · 2020Guideline
- A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection.The Journal of infectious diseases · 2015Pooled it
- Neuromodulation treats Chikungunya arthralgia: a randomized controlled trial.Scientific reports · 2018Trial
- Article
- Article
- Chikungunya fever: pathogenesis and mechanisms underlying pain symptoms.Frontiers in immunology · 2025Review
- Acute Clinical Features and Persistence of Joint Pain in Probable Cases of Chikungunya Fever in Eritrea.Open access rheumatology : research and reviews · 2025Article
- Impact of chronic illness caused by chikungunya fever on quality of life and functionality.Einstein (Sao Paulo, Brazil) · 2024Article
- Estimated annual costs of Chikungunya fever in the municipality of Rio de Janeiro, Brazil.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2024Article
- Chikungunya fever.Nature reviews. Disease primers · 2023Review
- The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospective cohort study in Curaçao.BMC infectious diseases · 2022Article
- Role of Arbovirus Infection in Arthritogenic Pain Manifestation-A Systematic Review.Tropical medicine and infectious disease · 2022Review
- Crystal structures of alphavirus nonstructural protein 4 (nsP4) reveal an intrinsically dynamic RNA-dependent RNA polymerase fold.Nucleic acids research · 2022Article
- The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses.Pathogens (Basel, Switzerland) · 2022Article
- Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study.European journal of pain (London, England) · 2021Article
- Chikungunya Manifestations and Viremia in Patients WhoPresented to the Fever Clinic at Bangkok Hospital for Tropical Diseases during the 2019 Outbreak in Thailand.Tropical medicine and infectious disease · 2021Article
- Rheumatic manifestations of Chikungunya virus infection: Prevalence, patterns, and enthesitis.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChikungunya virus (CHIKV) is responsible for major epidemics worldwide. Autochthonous cases were recently reported in several European countries. Acute infection is thought to be monophasic. However reports on chronic pain related to CHIKV infection have been made. In particular, the fact that many of these patients do not respond well to usual analgesics suggests that the nature of chronic pain may be not only nociceptive but also neuropathic. Neuropathic pain syndromes require specific treatment and the identification of neuropathic characteristics (NC) in a pain syndrome is a major step towards pain control.
methodsWe carried out a cross-sectional study at the end of the major two-wave outbreak lasting 17 months in Réunion Island. We assessed pain in 106 patients seeking general practitioners with confirmed infection with the CHIK virus, and evaluated its impact on quality of life (QoL).
resultsThe mean intensity of pain on the visual-analogical scale (VAS) was 5.8 +/- 2.1, and its mean duration was 89 +/- 2 days. Fifty-six patients fulfilled the definition of chronic pain. Pain had NC in 18.9% according to the DN4 questionnaire. Conversely, about two thirds (65%) of patients with NC had chronic pain. The average pain intensity was similar between patients with or without NC (6.0 +/- 1.7 vs 6.1 +/- 2.0). However, the total score of the Short Form-McGill Pain Questionnaire (SF-MPQ)(15.5 +/- 5.2 vs 11.6 +/- 5.2; p < 0.01) and both the affective (18.8 +/- 6.2 vs 13.4 +/- 6.7; p < 0.01) and sensory subscores (34.3 +/- 10.7 vs 25.0 +/- 9.9; p < 0.01) were significantly higher in patients with NC. The mean pain interference in life activities calculated from the Brief Pain Inventory (BPI) was significantly higher in patients with chronic pain than in patients without it (6.8 +/- 1.9 vs 5.9 +/- 1.9, p < 0.05). This score was also significantly higher in patients with NC than in those without such a feature (7.2 +/- 1.5 vs 6.1 +/- 1.9, p < 0.05).
conclusionsThere exists a specific chronic pain condition associated to CHIKV. Pain with NC seems to be associated with more aggressive clinical picture, more intense impact in QoL and more challenging pharmacological treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.